Monday, October 05, 2015 9:47:58 AM
Why do you post sick long detailed reports in stocks you aren't in?
You are either justifying why you left to yourself and trying to get others to leave with you. Are paid to do it. Or have kind of a sad life. You should be ihub that time researching other stocks.
This is a great long term hold with an extremely low market cap vs potential. That's why people are investing. It has hit a rock bottom considering cash on hand. That's why people invest.
If you want a stock that's going to regularly surprise your account for the next year or two this is a good one.
If yout want 1000% in a day. Probably not.
Either way you're spending a suspicious amount of time bashing this stock because your freind Sheff doesn't like it. And you likely need to feel better about not investing. Which I understand. Sometimes I can be a twerp like that too.
The fact is considering cash on hand the market cap is rock bottom. And anything could send it up 20 to 50 %.. great unexpected news could seems it up 100s of percentage points.
Recent CSCI News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/08/2024 11:30:21 AM
- COSCIENS Biopharma Announces Change to Board of Directors • GlobeNewswire Inc. • 10/08/2024 11:30:00 AM
- COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director • GlobeNewswire Inc. • 10/01/2024 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/01/2024 09:29:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 11:30:23 AM
- COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs • GlobeNewswire Inc. • 09/23/2024 11:30:00 AM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 09/06/2024 06:04:41 PM
- COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency • GlobeNewswire Inc. • 08/27/2024 11:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/13/2024 12:05:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/13/2024 12:05:17 PM
- COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 12:05:00 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM